Eliot A. Brinton

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller et al. · New England Journal of Medicine · 2018 · 3.1K citations

American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease

Paul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit et al. · Endocrine Practice · 2017 · 1.1K citations

Metabolic Syndrome, Cardiovascular Disease, Health Policy +7

Weight and Metabolic Outcomes 12 Years after Gastric Bypass

Ted D. Adams, Lance E. Davidson, Sheldon E. Litwin et al. · New England Journal of Medicine · 2017 · 891 citations · Full text

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

Christopher P. Cannon, Sukrut Shah, Hayes M. Dansky et al. · New England Journal of Medicine · 2010 · 746 citations · Full text

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Aruna D. Pradhan, Robert J. Glynn, Jean‐Charles Fruchart et al. · New England Journal of Medicine · 2022 · 638 citations · Full text